BONDLIDO

Product NDC
53225-1111
11-digit product format
532251111
Labeler code
53225
Product ID
53225-1111_5cca5e32-619b-bb4a-e063-6294a90ad7bb
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
lidocaine
Dosage form
SYSTEM
Route
TOPICAL
Labeler
Terrain Pharmaceuticals, Inc.
Application
NDA215029
Marketing category
NDA
Marketing start
2026-09-08
Substance
LIDOCAINE
Active strength
200 mg/1
Pharmacologic classes
Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N215029-001BONDLIDOLIDOCAINE10%SYSTEM / TOPICALRLD, RS2025-09-24

Orange Book patents#

Current patent rows page 1 of 1 · 1 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N215029-00187220652028-11-10Drug product2026-09-10

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 1 matching rows.

Application-product, Exclusivity code, Expiration table
Application-productExclusivity codeExpiration
N215029-001NP2028-09-24

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N215029-001BONDLIDO10%SYSTEM / TOPICALRLD, RS2025-09-24d4dbc9d85df4…
2026-10-15 13:18:302026-09N215029-001BONDLIDO10%SYSTEM / TOPICALRLD, RS2025-09-24c2088c7a36db…
2026-09-14 22:38:342026-08N215029-001BONDLIDO10%SYSTEM / TOPICALRLD, RS2025-09-2484e616aacf4f…
2026-08-18 06:07:402026-07N215029-001BONDLIDO10%SYSTEM / TOPICALRLD, RS2025-09-24caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N215029-001BONDLIDO10%SYSTEM / TOPICALRLD, RS2025-09-24011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N215029-001BONDLIDO10%SYSTEM / TOPICALRLD, RS2025-09-2431067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N215029-001BONDLIDO10%SYSTEM / TOPICALRLD, RS2025-09-24a50c72e98297…

Observed Orange Book patent history#

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-11-14 07:37:172026-10N215029-00187220652028-11-10Drug product2026-09-10d4dbc9d85df4…
2026-10-15 13:18:302026-09N215029-00187220652028-11-10Drug product2026-09-10c2088c7a36db…
2026-09-14 22:38:342026-08N215029-00187220652028-11-10Drug product2026-09-1084e616aacf4f…

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
CapturedEditionApplication-productExclusivity codeExpirationSource SHA-256
2026-11-14 07:37:172026-10N215029-001NP2028-09-24d4dbc9d85df4…
2026-10-15 13:18:302026-09N215029-001NP2028-09-24c2088c7a36db…
2026-09-14 22:38:342026-08N215029-001NP2028-09-2484e616aacf4f…
2026-08-18 06:07:402026-07N215029-001NP2028-09-24caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N215029-001NP2028-09-24011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N215029-001NP2028-09-2431067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N215029-001NP2028-09-24a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
BONDLIDO
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
LIDOCAINE200 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
98PI200987Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2754390Internal RxNorm lookup
2754395Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
4b206c72-adf2-ba48-e063-6294a90a3840Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BONDLIDOLIDOCAINETerrain Pharmaceuticals, Inc.4b206c72-adf2-ba48-e063-6294a90a38402026-09-30Warnings, Adverse reactionsExact identifier
application applno (NDA): 215029
application number: NDA215029
ndc (product): 53225-1111
BONDLIDOLIDOCAINEMEDRx USA, Inc.17e69028-d2c2-4080-8090-cb0cab5701962025-10-06Warnings, Adverse reactionsExact identifier
application applno (NDA): 215029
application number: NDA215029

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
53225-1111-35322511110328 POUCH in 1 CARTON (53225-1111-3) / 1 PATCH in 1 POUCH (53225-1111-1) / 1 SYSTEM in 1 PATCH28 pouch2026-09-08NoNoCurrent